{
    "Trade/Device Name(s)": [
        "BioCode Gastrointestinal Pathogen Panel (GPP)"
    ],
    "Submitter Information": "Applied BioCode, Inc.",
    "510(k) Number": "K190585",
    "Predicate Device Reference 510(k) Number(s)": [
        "K180041"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PCH",
        "OOI"
    ],
    "Summary Letter Date": "March 4, 2019",
    "Summary Letter Received Date": "March 6, 2019",
    "Submission Date": "March 5, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3990"
    ],
    "Regulation Name(s)": [
        "Gastrointestinal microorganism multiplex nucleic acid-based assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology",
        "parisitology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Campylobacter (C. jejuni/C. coli)",
        "Clostridium difficile toxin A/B",
        "Salmonella spp",
        "Vibrio (V. parahaemolyticus/V. vulnificus/V. cholerae)",
        "Yersinia enterocolitica",
        "Enteroaggregative Escherichia coli (EAEC)",
        "Enterotoxigenic Escherichia coli (ETEC) lt/st",
        "E. coli O157 serogroup",
        "Shiga-like toxin-producing Escherichia coli (STEC) stx1/stx2",
        "Shigella/Enteroinvasive Escherichia coli (EIEC)",
        "Cryptosporidium spp (C. parvum/C. hominis)",
        "Entamoeba histolytica",
        "Giardia lamblia (G. intestinalis/G. duodenalis)",
        "Adenovirus F 40/41",
        "Norovirus GI/GII",
        "Rotavirus A"
    ],
    "Specimen Type(s)": [
        "Unpreserved stool",
        "Stool preserved in Cary-Blair transport medium"
    ],
    "Specimen Container(s)": [
        "Standard stool container",
        "Cary-Blair transport medium"
    ],
    "Instrument(s)/Platform(s)": [
        "BioCode MDx 3000 Instrument",
        "Roche MagNA Pure 96",
        "easyMAG"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex RT-PCR",
        "Probe hybridization",
        "Fluorescence detection",
        "Decoding of barcoded magnetic beads"
    ],
    "Methodologies": [
        "Multiplexed nucleic acid amplification",
        "Probe hybridization",
        "Automated qualitative detection"
    ],
    "Submission Type(s)": [
        "Panel",
        "Assay",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for BioCode Gastrointestinal Pathogen Panel (GPP) for multiplexed nucleic acid detection of GI pathogens using automated PCR/hybridization workflow",
    "Indications for Use Summary": "Qualitative multiplexed nucleic acid-based in vitro diagnostic test to simultaneously detect and identify nucleic acids from multiple bacteria, viruses, and parasites in stool samples from individuals with signs/symptoms of gastrointestinal infection, for use with BioCode MDx 3000 Instrument; aids diagnosis of GI illness to be interpreted with clinical, laboratory, and epidemiological data",
    "fda_folder": "Microbiology"
}